Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature

Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature

(2015) Sergio Di Nuzzo et al.   DERMATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis

(2014) Raquel Navarro et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis

(2013) Kiran Motaparthi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review

(2013) Maurizio Pompili   WORLD JOURNAL OF GASTROENTEROLOGY

Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting

(2012) R. Navarro et al.   BRITISH JOURNAL OF DERMATOLOGY

Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management

(2012) Amanda Abramson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan

(2011) Yung-Tsu CHO et al.   JOURNAL OF DERMATOLOGY

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection

(2010) L. Nosotti et al.   BRITISH JOURNAL OF DERMATOLOGY

Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action

(2010) Matthew B. Carroll et al.   CLINICAL RHEUMATOLOGY

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature

(2010) C Fotiadou et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab

(2009) Antonio Giovanni Richetta et al.   Dermatologic Therapy

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection

(2009) Alberto Conde-Taboada et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases

(2008) I. Cavazzana et al.   AUTOIMMUNITY REVIEWS